These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 13260705)

  • 1. [Report of 26 cases of osteoarticular tuberculosis treated with dihydrostreptomycin triisonicotinylhydrazone of pyruvic acid].
    BLANKOFF B; PARISEL-LECLERCQ F; PARISEL-LECLERCQ A; KINZINGER
    Brux Med; 1955 Sep; 35(36):1777-90. PubMed ID: 13260705
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of diminished toxicity of dihydrostreptomycin on the treatment of osteoarticular tuberculosis].
    GLOGOWSKI G
    Medizinische; 1955 Aug; (33-34):1121-6. PubMed ID: 13265062
    [No Abstract]   [Full Text] [Related]  

  • 3. Experimental studies on the treatment of bone and joint tuberculosis with dihydrostreptomycin and isonicotinic acid hydrazide.
    MORA FB; LLAMEDO LP
    J Bone Joint Surg Am; 1955 Jan; 37-A(1):156-68. PubMed ID: 13233280
    [No Abstract]   [Full Text] [Related]  

  • 4. [Results of treatment of pulmonary tuberculosis with dihydrostreptomycin triisonicotinylhydrazone of pyruvic acid].
    REY JC; RUBINSTEIN P
    Prensa Med Argent; 1954 Jul; 41(30):2150-6. PubMed ID: 13236897
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical and bacteriological findings with dihydrostreptomycin triisonicotinylhydrazone of pyruvic acid].
    REY JC; RUBINSTEIN P; CETRANGOLO A
    Prensa Med Argent; 1954 Jul; 41(31):2209-13. PubMed ID: 13236902
    [No Abstract]   [Full Text] [Related]  

  • 6. [A new salt of dihydrostreptomycin: tri-2-(1-isonicotinoylhydrazono)-pyruvate of dihydrostreptomycin. II. Comparison of the toxicity of tri-2(1-isonicotinoylhydrazono)-pyruvate of dihydrostreptomycin with that of dihydrostreptomycin sulfate; effects of anion on dihydrostreptomycin toxicity].
    AGUIRRE MIQUEO D; VAZQUEZ LOPEZ F
    Arch Inst Farmacol Exp (Madr); 1954; 6(1):106-19. PubMed ID: 13239437
    [No Abstract]   [Full Text] [Related]  

  • 7. [A new salt of dihydrostreptomycin: tri-2-(1-isonicotinoylhydrazono)-pyruvate of dihydrostreptomycin. I. Characterization and spectrophotometric properties].
    VAZQUEZ LOPEZ F; AGUIRRE MIQUEO D
    Arch Inst Farmacol Exp (Madr); 1954; 6(1):91-105. PubMed ID: 13239436
    [No Abstract]   [Full Text] [Related]  

  • 8. [Trial therapy of osteoarticular tuberculosis with a new antibiotic compound].
    BLANKOFF B; PARISEL-LECLERCQ A; KINZINGER H
    Acta Orthop Belg; 1955; 21(6):543-64. PubMed ID: 13301655
    [No Abstract]   [Full Text] [Related]  

  • 9. [Combined dihydrostreptomycin and isoniazid in the form of tri-isonicotinoyl-hydrazone-dihydrostreptomycin pyruvate; research in vivo and in vitro].
    BARTOLOZZI G; RAPI G
    Riv Clin Pediatr; 1955 Aug; 56(2):188-203. PubMed ID: 13290577
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of the anaerobic pyruvate metabolism of Escherichia coli by dihydrostreptomycin.
    BARKULIS IL
    J Bacteriol; 1953 Mar; 65(3):337-43. PubMed ID: 13034748
    [No Abstract]   [Full Text] [Related]  

  • 11. [Preliminary data on clinical tolerance of paratebin with pantothenate].
    RAUSCH E
    Munch Med Wochenschr; 1955 Dec; 97(48):1625-6. PubMed ID: 13288490
    [No Abstract]   [Full Text] [Related]  

  • 12. [Trials with streptotibine in orthopedics].
    JOVENEAU G
    Scalpel (Brux); 1955 Jul; 108(28):738-41. PubMed ID: 13246594
    [No Abstract]   [Full Text] [Related]  

  • 13. [Combined treatment of bone and bladder tuberculosis with paratebin and nevin].
    SCHUCK RA
    Munch Med Wochenschr; 1954 Sep; 96(38):1096-8. PubMed ID: 13223682
    [No Abstract]   [Full Text] [Related]  

  • 14. Reduced neurotoxicity in the treatment of tuberculosis by combined streptomycin-dihydrostreptomycin therapy.
    HECK WE; LYNCH WJ; GRAVES HL
    Acta Otolaryngol; 1953; 43(4-5):416-20. PubMed ID: 13104135
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of pulmonary tuberculosis with a stable salt of dihydrostreptomycin: triisonicotinylhydrazone pyruvate].
    CANTONI E
    G Ital Della Tuberc; 1954; 8(6):342-50. PubMed ID: 14366346
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of carbon dioxide and aging on the dihydrostreptomycin inhibition of pyruvate fermentation in Escherichia coli.
    ZEBOVITZ E; MOULDER JW
    J Bacteriol; 1953 Mar; 65(3):344-7. PubMed ID: 13034749
    [No Abstract]   [Full Text] [Related]  

  • 17. [Osteoarticular tuberculosis treated locally by streptomycin].
    KLEBANOWSKI J
    Pol Przegl Chir; 1959 May; 31():549-53. PubMed ID: 14409624
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on the action of antibiotics on bacterial metabolism. III. Effect of dihydrostreptomycin on anaerobic pyruvate metabolism of Escherichia coli.
    KATAGIRI H; SUZUKI Y; TOCHIKURA T
    J Antibiot (Tokyo); 1960 May; 13():164-71. PubMed ID: 13853316
    [No Abstract]   [Full Text] [Related]  

  • 19. [Value of dihydrostreptomycin pantothenate in the prevention of accidents during intensive treatment of tuberculosis].
    CELICE J; AUBRY M; PLAS F; DUCHESNAY G
    Bull Mem Soc Med Hop Paris; 1956 Feb 24-Mar 2; 72(7-8):237-46. PubMed ID: 13304664
    [No Abstract]   [Full Text] [Related]  

  • 20. [First clinical trials with dihydrostreptomycin pantothenate].
    LESOBRE R; VERNEY H
    Bull Mem Soc Med Hop Paris; 1956 Feb 24-Mar 2; 72(7-8):227-37. PubMed ID: 13304663
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.